Apalutamide

Back to search
Scientific Name: Apalutamide
Brand Name: Erleada
Company Owner: Not Available
Mechanism Of Action Persistent androgen receptor (AR) signaling is a common feature of castration-resistant prostate cancer (CRPC) , attributed to AR gene-amplification, AR gene mutation, increased AR expression or increased androgen biosynthesis in prostate tumors
Description of the Drug: Apalutamide is an androgen receptor inhibitor used to treat non metastatic, castration resistant prostate cancer.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB11901